Department of Ophthalmology & Clinical Centre of Optometry, Peking University People's Hospital, Beijing, China.
Institute of Medical Technology, Peking University Health Science Center, Beijing, China.
Eye (Lond). 2024 Jun;38(9):1660-1667. doi: 10.1038/s41433-024-02987-5. Epub 2024 Feb 28.
The aim of this study was to evaluate the efficacy of Orthokeratology (Ortho-K), defocus incorporated multiple segment (DIMS) lens, combined Ortho-K/atropine, and combined DIMS/atropine for myopia control in children.
A retrospective study included 167 myopic children aged 6-14 years with a spherical equivalent refraction (SER) of -0.75 to -4.00 diopter treated with Ortho-K (OK, n = 41), combined Ortho-K/atropine (OKA, n = 43), DIMS (n = 41), or combined DIMS/atropine (DIMSA, n = 42). Axial length (AL) was measured at baseline and at 3, 6, 9 and 12 months. Axial elongation over time and between groups were analysed.
After 12 months, the AL change was 0.20 ± 0.12 mm, 0.12 ± 0.14 mm, 0.22 ± 0.14 mm, and 0.15 ± 0.15 mm in the OK, OKA, DIMS, and DIMSA, respectively. There was no significant difference in AL change between OK and DIMS. OKA and DIMSA significantly slowed axial elongation compared to OK and DIMS monotherapy. After stratification by age, in the subgroup aged 6-10 years, there was significant difference in AL change between OKA and DIMS (p = 0.013), and no difference between other groups, while in the subgroup aged 10-14 years, the difference between OKA and DIMS became insignificant (p = 0.237), and the difference between OK and OKA, OK and DIMSA, DIMS and DIMSA became significant.
Ortho-K and DIMS lenses show similar reductions in myopia progression among children with low initial myopia. Atropine can significantly improve the efficacy of myopia control of both Ortho-K and DIMS lenses, and this add-on effect is better in older children.
本研究旨在评估角膜塑形术(Ortho-K)、离焦多焦点(DIMS)镜片、联合 Ortho-K/阿托品和联合 DIMS/阿托品对儿童近视控制的疗效。
回顾性研究纳入了 167 名年龄在 6-14 岁、等效球镜(SER)为-0.75 至-4.00 屈光度的近视儿童,他们分别接受了角膜塑形术(OK,n=41)、联合角膜塑形术/阿托品(OKA,n=43)、离焦多焦点(DIMS,n=41)或联合离焦多焦点/阿托品(DIMSA,n=42)治疗。在基线和 3、6、9 和 12 个月时测量眼轴长度(AL)。分析随时间和组间的轴向伸长。
12 个月后,OK、OKA、DIMS 和 DIMSA 组的 AL 变化分别为 0.20±0.12、0.12±0.14、0.22±0.14 和 0.15±0.15。与 OK 相比,OKA 和 DIMSA 对眼轴伸长的抑制作用无显著差异。与 OK 和 DIMS 单药治疗相比,OKA 和 DIMSA 显著减缓了轴向伸长。按年龄分层后,在 6-10 岁年龄组中,OKA 和 DIMS 之间的 AL 变化差异有统计学意义(p=0.013),而其他组之间无差异,而在 10-14 岁年龄组中,OKA 和 DIMS 之间的差异变得无统计学意义(p=0.237),而 OK 和 OKA、OK 和 DIMSA、DIMS 和 DIMSA 之间的差异变得有统计学意义。
角膜塑形术和离焦多焦点镜片在低初始近视的儿童中显示出相似的近视进展减少。阿托品可显著提高角膜塑形术和离焦多焦点镜片控制近视的疗效,且这种附加作用在年龄较大的儿童中更好。